Electromed, Inc.
500 6th Ave NW
New Prague
Minnesota
56071
United States
Tel: 800-462-1045 or 952-758-9299
Fax: 866-758-5077
Website: http://www.electromed.com/info_pages/elect...
Email: info@electromed.com
133 articles about Electromed, Inc.
-
Electromed, Inc. Schedules its First Quarter Fiscal 2023 Financial Results Conference Call for November 8, 2022 at 5:00 p.m. PT
10/25/2022
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD today announced that it will issue its financial results press release for the fiscal 2023 first quarter ended September 30, 2022, on Tuesday, November 8, 2022 after the close of the stock market, and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.
-
Electromed, Inc. Appoints Brad Nagel as Chief Financial Officer
10/24/2022
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its Board of Directors has appointed Brad Nagel as the Company’s Chief Financial Officer, effective November 14, 2022.
-
Electromed, Inc. to Participate in the Issuer Direct 2022 Windy City Roundup
9/28/2022
Electromed, Inc. announced that Kathleen Skarvan, President and Chief Executive Officer, and Michelle Wirtz, Interim Chief Financial Officer, are scheduled to participate at the Issuer Direct 2022 Windy City Roundup on October 12-13, 2022.
-
Electromed, Inc. Announces Election of Andrew Summers as Additional Independent Director
7/25/2022
Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it has elected a new independent director, Andrew Summers, to its Board of Directors.
-
Electromed, Inc. Announces Clinical Abstract Poster at ATS Conference: Bronchiectasis Patients Showed Improved Outcomes and Reduction in Healthcare Resource Utilization When Using HFCWO Therapy
5/19/2022
Electromed, Inc. announced the results of a third-party, clinical study presented as a clinical abstract poster at the American Thoracic Society International Conference in San Francisco, CA.
-
Electromed, Inc. Announces Third Quarter Financial Results
5/10/2022
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for its fiscal 2022 third quarter ended March 31, 2022.
-
Electromed, Inc. to Participate in the Sidoti & Co. May Micro Cap Virtual Investor Conference
5/3/2022
Electromed, Inc., a leader in innovative airway clearance technologies, announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in the Sidoti May Virtual Micro Cap Investor Conference on May 11-12, 2022.
-
Electromed, Inc. Schedules its Third Quarter Fiscal 2022 Financial Results Conference Call for May 10, 2022 at 5:00 p.m. ET
4/19/2022
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2022 third quarter ended March 31, 2022, on Tuesday, May 10, 2022 after the close of the stock market, and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.
-
Electromed, Inc., Appoints Christopher Holland Chief Commercial Officer
2/16/2022
Electromed, Inc. today announced the appointment of Christopher Holland as Chief Commercial Officer.
-
Electromed, Inc. Announces Second Quarter 2022 Financial Results
2/8/2022
Record quarterly net revenues of $10.2 million while continuing to execute key strategic growth initiatives
-
Electromed, Inc. Schedules its Second Quarter Fiscal 2022 Financial Results Conference Call for February 8, 2022 at 5:00 p.m. ET
1/27/2022
Electromed, Inc. today announced that it will issue its financial results press release for the fiscal 2022 second quarter ended December 31, 2021, on Tuesday, February 8, 2022 after the close of the stock market, and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.
-
Electromed, Inc. to Participate in the Sidoti December Virtual Micro Cap Investor Conference
11/29/2021
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in the Sidoti December Virtual Micro Cap Investor Conference on December 8-9, 2021.
-
Electromed, Inc. Announces Fiscal 2022 First Quarter Financial Results
11/9/2021
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2021 (“Q1 FY 2022”).
-
Electromed, Inc. Schedules its First Quarter Fiscal 2022 Financial Results Conference Call for November 9, 2021 at 5:00 p.m. ET
10/26/2021
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), today announced that it will issue its financial results press release for the fiscal 2022 first quarter ended September 30, 2021, on Tuesday, November 9, 2021 after the close of the stock market and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.
-
Electromed, Inc. to Participate in the 2021 Colliers Institutional Investor Conference
8/31/2021
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in the 2021 Colliers Institutional Investor Conference, which will be held virtually, on Thursday, September 9, 2021.
-
Electromed, Inc. Announces Fiscal 2021 Fourth Quarter and Full Year Financial Results
8/24/2021
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months (“Q4 FY 2021”) and full year (“FY 2021”) ended June 30, 2021.
-
Electromed, Inc. Schedules its Fourth Quarter Fiscal 2021 Financial Results Conference Call for August 24, 2021 at 5:00 p.m. ET
8/16/2021
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2021 fourth quarter ended June 30, 2021, on Tuesday, August 24, 2021 after the close of the stock market and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.
-
Electromed, Inc. Announces Select Preliminary Unaudited Financial Results for Fourth Quarter Fiscal 2021
8/9/2021
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced select preliminary unaudited financial results for the three months ended June 30, 2021 (“Q4 FY 2021”).
-
Electromed, Inc. to Participate in Canaccord Genuity’s 41st Annual Growth Conference
8/2/2021
Electromed, Inc. today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in Canaccord Genuity’s 41st Annual Growth Conference, to be held virtually, on August 10-12, 2021.
-
Electromed, Inc. Announces Authorization of $3.0 Million Stock Repurchase Program
5/27/2021
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its Board of Directors has approved a $3.0 million stock repurchase authorization, effective as of May 26, 2021.